Sandoz posts steady FY24 results, cautious FY25 outlook, Biosimilars in focus


Sandoz publishes firm results FY24, careful FY25 prospects, biosimilars in Focus , #Sandoz #posts #steady #FY24 #results #cautious #FY25 #outlook #Biosimilars #focus

Leave a Reply

Your email address will not be published. Required fields are marked *